Blueberries Medical Announces C$1 Million Non-Brokered Private Placement
TORONTO, March 07, 2025 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the 'Company' or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce a non-brokered private placement consisting of the sale of 96,064,935 common shares ('Common Shares') at a price of C$0.011 per Common Share for aggregate gross proceeds of approximately C$1.05 million (or approximately US$740,000) (the 'Offering'). The net proceeds from the sale of the Common Shares are expected to fund and expand operations, for general corporate and working capital purposes. The Offering is expected to close on or about March 25, 2024.
It is expected that the Offering will be led by Terraflos Inc. ('Terraflos'), a cannabis company with operations throughout Latin America that was founded, and is controlled, by Facundo Garreton, the Chairman, Chief Executive Officer and a director of Blueberries. Guillermo Rodriguez, a director of the Company, is also expected to participate in the Offering.
Participation by Terraflos and Messrs. Garreton and Rodriguez (collectively, the 'Insiders') in the Offering will be considered a 'related party transaction' pursuant to Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions ('MI 61-101'). The Company will be exempt from the requirements to obtain a formal valuation or minority shareholder approval in connection with the participation of the Insiders in the Offering in reliance of sections 5.5(b) and 5.7(1)(b) of MI 61-101. A material change report will be filed in connection with the participation by the Insiders in the Offering less than 21 days in advance of the closing of the Offering, which the Company deemed reasonable in the circumstances so as to be able to avail itself of potential financing opportunities and complete the Offering in an expeditious manner.
About Blueberries Medical Corp.
Blueberries is a Latin American licensed producer of premium quality cannabis derivatives with its primary operations ideally located in the Bogotá Savannah of central Colombia. The Company is led by a specialized team with proprietary expertise in agriculture, genetics, extraction, medicine, pharmacology and marketing, Blueberries is fully licensed for the cultivation, production, domestic distribution, and international export of CBD and THC-based medical cannabis in Colombia. Blueberries' combination of leading scientific expertise, agricultural advantages and distribution arrangements has positioned the Company to become a leading international supplier of naturally grown, processed, and standardized medicinal-grade cannabis oil extracts and related products.
Additional information about the Company is available at www.blueberriesmed.com. For more information, please contact:
Gustavo Gutiérrez, Country Manager, Colombia Operationsggutierrez@blueberriesmed.comTel: +57 317 667 4812
Thomas Rodriguez Prats, Chief Financial Officertrodriguez@blueberriesmed.com Tel: +57 311 617 4246
Cautionary Note Regarding Forward-Looking Information
This news release contains "forward-looking information" and "forward-looking statements" (collectively, "forward-looking statements") within the meaning of the applicable Canadian securities legislation. All statements, other than statements historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as 'expects', or 'does not expect', 'is expected', 'anticipates' or 'does not anticipate', 'plans', 'budget', 'scheduled', 'forecasts', 'estimates', 'believes' or 'intends' or variations of such words and phrases or stating that certain actions, events or results 'may' or 'could', 'would', 'might' or 'will' be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. In this news release, forward-looking statements relate, among other things, to: the use of proceeds from the Offering, commencement of commercial production of CBD-dominant oils and products, successful implementation of full GMP standards at its extraction facility to allow for additional export potential to international markets, achieving additional milestones is contemplated, or at all, ability to expand distribution networks, ability to expand and upgrade the Company's cultivation facilities in Colombia, internal expectations, expectations regarding the ability of the Company to access new Latin American and international markets, the ability to attract and retain new customers, and future expansion plans including development of the cultivation, production, industrialization and marketing of cannabis for commercial and scientific purposes.
These forward-looking statements are based on reasonable assumptions and estimates of management of the Company at the time such statements were made. Actual future results may differ materially as forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to materially differ from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors, among other things, include: fluctuations in general macroeconomic conditions; fluctuations in securities markets; expectations regarding the size of the Colombian and international medical cannabis market and changing consumer habits; the ability of the Company to successfully achieve its business objectives; plans for expansion; political and social uncertainties; inability to obtain adequate insurance to cover risks and hazards; and the presence of laws and regulations that may impose restrictions on cultivation, production, distribution and sale of cannabis and cannabis related products in Colombia, Argentina and elsewhere; and employee relations. Although the forward-looking statements contained in this news release are based upon what management of the Company believes, or believed at the time, to be reasonable assumptions, the Company cannot assure shareholders that actual results will be consistent with such forward-looking statements, as there may be other factors that cause results not to be as anticipated, estimated or intended. Readers should not place undue reliance on the forward-looking statements and information contained in this news release. The Company assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by law.
Additional information regarding the Company, and other risks and uncertainties relating to the Company's business are contained under the heading "Risk Factors" in the Company's Listing Statement dated January 31, 2019 and such other risk factors included in the management's discussion and analysis of the Corporation for the year ended December 31, 2023, each filed on its issuer profile on SEDAR+ at www.sedarplus.ca.
No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.Sign in to access your portfolio
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
38 minutes ago
- Yahoo
Court Reserves Judgement on both Judicial Review Petition and Injunction Application Relating to Mount Polley Tailings Storage Facility
VANCOUVER, British Columbia, June 30, 2025 (GLOBE NEWSWIRE) -- Imperial Metals Corporation (TSX:III) (the 'Company' or 'Imperial') announces that, further to the Company's news release dated May 9, 2025, following a four-day hearing, the Supreme Court of British Columbia has reserved judgment on the judicial review petition and injunction application filed by the Xatśūll First Nation ('Xatśūll') that challenged two provincial decisions authorizing a four-metre raise of the tailings storage facility embankment at the Mount Polley mine (the 'TSF Raise') until the Court issues its reasons for decision, expected on August 6, 2025. MPMC is permitted to continue construction of the four-metre raise as planned and operations at the mine continue in accordance with the permits granted by the Ministry of Mining and Critical Minerals and the Environmental Assessment Office. In the interim, MPMC has provided a voluntary undertaking to refrain from depositing tailings that rely on the TSF Raise until August 7, 2025 to allow the Court time to consider the matter. The petition and injunction were heard together on June 24-27, 2025. At the hearing, counsel for Mount Polley Mining Corporation ('MPMC'), Imperial's wholly owned subsidiary, and counsel for the Province of British Columbia argued the decisions are valid and were issued through the proper process with adequate consultation. Imperial and MPMC are committed to transparent engagement with Indigenous communities and environmental responsibility. Maintaining a meaningful relationship with Xatśūll and Williams Lake First Nation is important to the Company, including supporting sustainable development through meaningful dialogue. 'We appreciate the Court taking its time to carefully consider this matter and await its decision on the interlocutory injunction application and petition. We are committed to working collaboratively with Xatśūll and other Indigenous communities to address their concerns,' stated Brian Kynoch, President of Imperial. 'Our goal is to ensure that all operations at Mount Polley mine are conducted in an environmentally responsible manner that respects the rights of Indigenous peoples.' Imperial and MPMC will continue to work with provincial regulators and Indigenous communities to ensure future actions align with regulatory requirements and community expectations. About Imperial Imperial is a Vancouver-based exploration, mine development and operating company with holdings that include the Mount Polley mine (100%), the Huckleberry mine (100%), and the Red Chris mine (30%). Imperial also holds a portfolio of 23 greenfield exploration properties in British Columbia. Imperial Contacts Brian Kynoch | President | 604.669.8959Darb S. Dhillon | Chief Financial Officer | 604.669.8959 Cautionary Note Regarding Forward-Looking Statements Certain information contained in this news release are not statements of historical fact and are 'forward-looking' statements. Forward-looking statements relate to future events or future performance and reflect Imperial management's expectations or beliefs regarding future events, and include, but are not limited to statements regarding: Imperial's expectations and timing with respect to the construction and operation of the tailings storage facility at the Mount Polley mine, including the four-meter lift currently under construction; the anticipated progress and outcome of any remaining or future legal or regulatory processes; the possibility that future legal or regulatory developments could result in material changes to the provincial permitting process; the Company's and MPMC's expectations regarding their relationships with Indigenous communities, including Xatśūll; expectations regarding ongoing engagement with Xatśūll and other Indigenous communities during the permitting process; and other risks outlined in statements made by Imperial from time to time in the filings made by Imperial with securities regulators. Imperial disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by applicable securities legislation. In certain cases, forward-looking statements can be identified by the use of words such as 'plans', 'expects' or 'does not expect', 'is expected', 'is targeted', 'targets', 'outlook', 'budget', 'scheduled', 'estimates', 'forecasts', 'intends', 'anticipates' or 'does not anticipate', or 'believes', or variations of such words and phrases or statements that certain actions, events or results 'may', 'could', 'would', 'might' or 'will be taken', 'occur' or 'be achieved" or the negative of these terms or comparable terminology. By their very nature forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Imperial to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. In making the forward-looking statements in this news release, Imperial has applied certain factors and assumptions that are based on information currently available to Imperial as well as Imperial's current beliefs and assumptions. These factors and assumptions and beliefs and assumptions include, the risk factors detailed from time to time in Imperial's interim and annual financial statements and management's discussion and analysis of those statements, and the Company's current Annual Information Form, all of which are filed and available for review on SEDAR+ at Although Imperial has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended, many of which are beyond Imperial's ability to control or predict. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward looking statements and all forward-looking statements in this news release are qualified by these cautionary in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
43 minutes ago
- Yahoo
Australian Fintech Eightcap Debuts CoinDesk20 CFD for Retail Traders
Financial derivatives provider Eightcap is now offering a contract for difference (CFD) based on the CoinDesk 20 Index (CD20), which offers a weighted performance of the largest digital assets. The CD20 CFD is now available to traders in both fiat and USDT pairs as an over-the-counter (OTC) derivatives product to retail traders, according to an announcement on Monday. CFDs are derivatives instruments where traders and brokers exchange the difference in an asset's value at the opening and closing of a contract. The CD20 CFD will "bridge the gap between traditional finance and the digital asset space by delivering institutional-grade crypto index access within a robust, compliant framework," Eightcap said in the announcement. Melbourne-based Eightcap holds regulatory licenses in the U.K., European Union (EU) and Bahamas, as well as its native Australia. Provision for regulated CFDs represents growing maturity in the crypto industry as they provide traders with the type of investment products that they would recognize from the traditional financial (TradFi) world. Sign in to access your portfolio
Yahoo
43 minutes ago
- Yahoo
NU vs. DAVE: Which Fintech Stock Should Investors Back Right Now?
Both Nu Holdings NU and Dave DAVE are major players in the digital financial services sector. NU is a prominent digital bank serving more than 118 million customers across Brazil, Colombia and Mexico. DAVE is a U.S.-based financial services platform offering an array of financial products, including ExtraCash and Dave Banking. This comparative analysis helps investors develop their strategy to choose between these two stocks, allowing them to gain exposure in the fintech space. In conclusion, this analysis aims to make it easier for investors to decide which stock to support right now. NU is emerging as a formidable player within the fintech space. With 19% year-over-year growth in new customers in the first quarter of 2025 and nearly 100 million active users, the company is confident that it can scale rapidly without compromising its potential to generate revenues. Nu Holdings derives this growth momentum from its expansion in Brazil, where nearly 59% of the adult population is its customers. This ascent underscores the company's success in tapping into a previously underbanked population. From a financial perspective, NU's performance was exceptional in the quarter ending in March. First, the top line grew 40% year over year, with net income increasing 74% from the previous year. Monthly average revenues per active customer rose 5% from the previous quarter and 17% year over year on a FX-neutral basis, highlighting the company's strong potential for long-term monetization. Furthermore, the 15-90 NPL ratio increases by 60 basis points (bps), reflecting the continued strength of NU's underwriting and effective risk management strategy. There is no denying the fact that the company's astounding performance was further bolstered by NU's expansion in Mexico. Nubank Mexico witnessed a 67% year-over-year increase in the customer base to 11 million. That being said, the company obtained regulatory approval for its banking license in April, which unlocks product capabilities, boosts the ability to scale deposits and reinforces its long-term mission to drive financial inclusion. In doing so, we can expect NU to reap benefits exponentially not only from Brazil but also from Mexico, aiding its growth trajectory. We expect Nu Holdings to capture a greater market share as the Latin American fintech market grows, seeing an 8% CAGR from 2025 to 2030. DAVE is one of the leading neobanks in the United States that has distinguished itself by providing services like ExtraCash. With the fee structure being revised, ExtraCash has become more popular among the masses, driving the growth narrative of the company. In the first quarter of 2025, DAVE witnessed 46% growth in its ExtraCash originations, which had a positive impact on average revenues per user, as it increased 29% year over year Moving on, the company's financial position got solidified as the top line rallied 47% year over year. Adjusted EBITDA skyrocketed 235% year over year, which was certainly impressive, underscoring the company's robust operating leverage. With the addition of 569,000 members, Dave registered 15% year-over-year growth in its member base, a testament to its growing demand for its offerings. DAVE's ability to manage credit risk separates it from the rest. By utilizing CashAI, a proprietary underwriting engine, the company improved its credit performance significantly. It witnessed an 18% year-over-year enhancement in the 28-day delinquency rate and a reduction in the percentage of provision for credit losses to originations to 0.69% from the year-ago quarter's 0.94%. CashAI's ability to improve cost management had a distinct influence on Dave's profitability position. It led to a 67% year-over-year surge in non-GAAP variable profit, with variable margin growing 950 bps. Dave's sole focus on the U.S. market hinders its means of diversification. This provides the company with a bedrock of motive to expand into different markets. With the global fintech market anticipated to grow, witnessing a healthy 15.3% CAGR from 2025 to 2030, DAVE is presented with a massive opportunity to capture a larger market share. The Zacks Consensus Estimate for Nu Holdings' 2025 sales is pegged at $14.8 billion, hinting at 28.5% year-over-year growth. The consensus estimate for earnings is pegged at 54 cents, suggesting a 20% rise from the preceding year's actual. One earnings estimate for 2025 has moved north in the past 60 days, versus two southward revisions. Image Source: Zacks Investment Research The Zacks Consensus Estimate for Dave's 2025 sales is pegged at $474.4 million, indicating 36.7% year-over-year growth. The consensus estimate for earnings is $8.74 per share, suggesting a 66.8% year-over-year surge. Two earnings estimates for 2025 have moved north in the past 60 days, versus no southward revisions. Image Source: Zacks Investment Research Nu Holdings is currently trading at a forward 12-month P/E ratio of 20.21X, which is slightly below the 12-month median of 20.71X. Dave is trading at 24.64X, substantially lower than the 12-month median of 33.74X. Although both stocks are trading at a discount compared with their historical valuations, NU appears much cheaper than DAVE. Image Source: Zacks Investment Research Dave is a 'Buy,' driven by ExtraCash's product improvements and popularity, strong operating leverage and advanced credit risk management with CashAI. While the company focuses on the U.S. market, the growing global fintech landscape positions it to capture a larger market share. Although Nu Holdings presents a strong case, we urge investors to take a cautious approach and refrain from adding it to their portfolios. Our recommendation for NU is based on its top and bottom-line outlook, which is weaker than that of DAVE and its downward earnings estimates revision, hinting at a lack of analyst confidence. DAVE flaunts a Zacks Rank #1 (Strong Buy) and NU has a Zacks Rank #3 (Hold) at present. You can see the complete list of today's Zacks #1 Rank stocks here. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Nu Holdings Ltd. (NU) : Free Stock Analysis Report Dave Inc. (DAVE) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
